investigational protease inhibitor, Aptivus (tipranavir)

You'll hear about an investigational protease inhibitor, Aptivus (tipranavir).

It's the first NON-peptidic protease inhibitor (PI).

PIs have trouble adapting their shape when HIV protease enzymes mutate. Aptivus is more "flexible"...hopefully making it harder for resistance to develop.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote